Version 1
: Received: 24 July 2024 / Approved: 24 July 2024 / Online: 24 July 2024 (11:48:38 CEST)
How to cite:
Mohammed, D. A. G.; Abdulah, R. K.; Odhaib, S. A.; AlWaeli, D. K.; Altemimi, M. T. Barriers to Insulin Initiation for Patients with Type 2 Diabetes: A Cross-Sectional Study in Thi-Qar Province, Southern Iraq. Preprints2024, 2024071955. https://doi.org/10.20944/preprints202407.1955.v1
Mohammed, D. A. G.; Abdulah, R. K.; Odhaib, S. A.; AlWaeli, D. K.; Altemimi, M. T. Barriers to Insulin Initiation for Patients with Type 2 Diabetes: A Cross-Sectional Study in Thi-Qar Province, Southern Iraq. Preprints 2024, 2024071955. https://doi.org/10.20944/preprints202407.1955.v1
Mohammed, D. A. G.; Abdulah, R. K.; Odhaib, S. A.; AlWaeli, D. K.; Altemimi, M. T. Barriers to Insulin Initiation for Patients with Type 2 Diabetes: A Cross-Sectional Study in Thi-Qar Province, Southern Iraq. Preprints2024, 2024071955. https://doi.org/10.20944/preprints202407.1955.v1
APA Style
Mohammed, D. A. G., Abdulah, R. K., Odhaib, S. A., AlWaeli, D. K., & Altemimi, M. T. (2024). Barriers to Insulin Initiation for Patients with Type 2 Diabetes: A Cross-Sectional Study in Thi-Qar Province, Southern Iraq. Preprints. https://doi.org/10.20944/preprints202407.1955.v1
Chicago/Turabian Style
Mohammed, D. A. G., Dheya Kadhim AlWaeli and Mahmood Thamer Altemimi. 2024 "Barriers to Insulin Initiation for Patients with Type 2 Diabetes: A Cross-Sectional Study in Thi-Qar Province, Southern Iraq" Preprints. https://doi.org/10.20944/preprints202407.1955.v1
Abstract
Type 2 diabetes mellitus (T2DM) poses a significant economic and clinical burden. Clinical inertia is defined as the failure of healthcare providers to modify therapy in the presence of clear indications. This study aimed to identify patient opinions on insulin to understand the barriers preventing type 2 diabetes patients from initiating insulin treatment when recommended by their physician. This cross-sectional observational study included 671 individuals with poorly controlled T2DM and HbA1c levels exceeding 10%. These patients required either the initiation or escalation of their existing insulin therapy. The participants were referred to Thi-Qar Specialized Diabetes Endocrine and Metabolism Center (TDEMC) for consultation between January 2022 and July 2022.Results: During discussions between the researcher (clinician) and the inadequately controlled T2DM patients, the primary reasons for refusing insulin therapy were identified. These reasons included fear of injections, the belief that insulin induces dependence and is a last resort, concerns about hypoglycemia and complications, cost, difficulty in computing doses, social stigma, inconvenience and disruption to life and work, storage challenges, fear of weight gain, dependence on others, and lack of confidence.The study concludes that the clinical barriers faced by individuals who refuse the initiation of insulin therapy are diverse. The most common belief among the patients was that insulin leads to dependence (38%), while the smallest percentage cited a lack of confidence in insulin as an effective treatment for lowering hyperglycemia.
Keywords
type 2 diabetes; clinical inertia; barriers; glycemic control; insulin therapy
Subject
Medicine and Pharmacology, Dietetics and Nutrition
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
